 Source: Shutterstock PopTika Iveric Bio NASDAQ: ISEE stock is rising higher on Tuesday after the biopharmaceutical company revealed positive results from a Phase 3 clinical trial. That trial covered the use of Zimura in treating patients suffering from geographic atrophy GA. 